HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A therapeutic approach for female, relapsing genital lichen sclerosus: a single-center study.

AbstractOBJECTIVE:
To assess the efficacy of methylprednisolone aceponate 0.1% (MPA 0.1%) in female genital lichen sclerosus (GLS) and efficacy of MPA, tacrolimus or emollient for prevention of flares.
METHODS:
A single-center, retrospective study was conducted. At baseline, female patients with relapsing GLS (n = 46) were treated with MPA 0.1% applied once daily for 8 weeks. Visual Analog Scale (VAS) score for vulvar pruritus and Investigator's Global Assessment (IGA) score were recorded at baseline, weeks 8 and 20. At week 8, patients responsive to treatment (n = 38) were further treated with MPA 0.1% twice weekly (n = 15), tacrolimus once daily (n = 13) or topical emollient once daily (n = 10), as maintenance therapy until week 20.
RESULT:
Both VAS and IGA median score was significantly decreased from baseline to week 8 (p = 0.000). At week 20, both median VAS and IGA scores differed significantly between patients treated with emollient and patients treated with MPA 0.1% (p = 0.000) and patients treated with emollient and patients treated with tacrolimus (p = 0.000); patients treated with MPA 0.1% presented no significant difference in either median VAS score (p = 0.032) or median IGA score (p = 0.636) at week 20 compared to patients treated with tacrolimus.
CONCLUSIONS:
MPA 0.1% is effective in relapsing female GLS. MPA 0.1% and tacrolimus have equal efficacy in preventing relapses.
AuthorsAikaterini Patsatsi, Aikaterini Kyriakou, Dimitrios Vavilis, Athanasios Mantas, Christos Patsialas, Dimitrios Sotiriadis
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 24 Issue 5 Pg. 336-9 (Oct 2013) ISSN: 1471-1753 [Electronic] England
PMID23164046 (Publication Type: Journal Article)
Chemical References
  • Dermatologic Agents
  • Emollients
  • methylprednisolone aceponate
  • Tacrolimus
  • Methylprednisolone
Topics
  • Aged
  • Dermatologic Agents (administration & dosage)
  • Emollients (administration & dosage)
  • Female
  • Humans
  • Lichen Sclerosus et Atrophicus (drug therapy)
  • Methylprednisolone (administration & dosage, analogs & derivatives)
  • Middle Aged
  • Retrospective Studies
  • Secondary Prevention
  • Tacrolimus (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: